The reaffirmation removes near-term guidance uncertainty but provides no catalyst. Monitor the investor roadshow for any off-script commentary on Medicare Advantage enrollment trends or medical cost trends, which are the key swing factors for Humana's 2026 results.
Price Chart
Executive Summary
Humana filed an 8-K under Item 7.01 to reaffirm its FY 2026 guidance of at least $8.36 GAAP EPS and at least $9.00 adjusted EPS, consistent with the April 29, 2026 press release. The reaffirmation accompanies a month-long investor roadshow (June 1–30, 2026). No new financial data or changes to outlook were provided.
Key Facts
- FY 2026 GAAP EPS guidance reaffirmed at at least $8.36
- FY 2026 adjusted (non-GAAP) EPS guidance reaffirmed at at least $9.00
- Guidance is unchanged from the April 29, 2026 press release
- Management is meeting investors and analysts from June 1 to June 30, 2026
- Reconciliation: GAAP EPS $8.36 + $0.30 amortization - $0.28 put/call adjustments + $0.81 value creation initiatives - $0.19 cumulative net tax impact = adjusted EPS $9.00
Financial Impact
No new financial data; existing guidance of at least $8.36 GAAP EPS and at least $9.00 adjusted EPS for FY 2026 reaffirmed.
Risk Factors
- No change to guidance — any deterioration in fundamentals since April 29 is not reflected
- GAAP EPS guidance subject to change due to ongoing value creation initiatives, per the filing
- Reaffirmation does not address potential headwinds from Medicare Advantage rate changes or utilization trends
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000049071-26-000027 |
| Document: 0000049071-26-000027-index-headers.html | 0000049071-26-000027 |
| Document: 0000049071-26-000027-index.html | 0000049071-26-000027 |
| Document: 0000049071-26-000027.txt | 0000049071-26-000027 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $394.45 $381.57 | ▼ −3.26% | ▼ −3.58% | $383.50 (−2.78%) |
Aug 17, 2026 6w ago | Institutional Cluster | $382.00 $384.72 | ▲ +0.71% | ▲ +2.02% | $383.50 (+0.39%) |
Aug 13, 2026 7w ago | Court Ruling | $384.97 $409.80 | ▲ +6.45% | ▲ +8.20% | $383.50 (−0.38%) |
Jul 29, 2026 9w ago | 8-K | $365.41 $391.06 | ▲ +7.02% | ▲ +2.00% | $383.50 (+4.95%) |
Jun 1, 2026 17w ago | 8-K | $328.31 $388.90 | ▲ +18.46% | ▲ +20.77% | $383.50 (+16.81%) |
Apr 10, 2026 24w ago | 8-K | $197.53 $274.15 | ▲ +38.79% | ▲ +31.06% | $383.50 (+94.15%) |
Mar 6, 2026 30w ago | DEFA14A | $179.09 $182.71 | ▲ +2.02% | ▲ +4.07% | $383.50 (+114.14%) |
Mar 2, 2026 30w ago | Court Ruling | $187.00 $166.00 | ▼ −11.23% | ▼ −3.29% | $383.50 (+105.08%) |
Mar 2, 2026 30w ago | Court Ruling | $187.00 $166.00 | ▼ −11.23% | ▼ −3.29% | $383.50 (+105.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access